Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014

Autor: Bahlis, Nizar J., Samaras, Christy, Reece, Donna, Sebag, Michael, Matous, Jeffrey, Berdeja, Jesús G., Shustik, Jesse, Schiller, Gary J., Ganguly, Siddhartha, Song, Kevin, Seet, Christopher S., Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald, Fonseca, Gustavo, Liu, Hongjuan, Gentili, Christian, Singh, Pavit, Siegel, David
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia December 2024 24(12):852-862
Databáze: ScienceDirect